Michelle Genova
Michelle Genova
Research Scientist
Michelle Genova has been with Peptimmune since its inception and is responsible for the in vitro and ex vivo evaluation of copolymers in the indications of multiple sclerosis and pemphigus vulgaris. Michelle has more than seventeen years of experience in biotechnology research and development, with expertise in flow cytometry and immunological assays. Prior to joining Peptimmune, she managed the core flow cytometry facility at the Rockefeller University in Manhattan.
